valine and Colorectal Neoplasms

valine has been researched along with Colorectal Neoplasms in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's5 (31.25)29.6817
2010's8 (50.00)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Fan, M; Gao, Y; Gu, Y; Jin, W; Li, X; Luo, Q; Shan, C; Shan, Y; Sun, L; Wang, Y; Xu, Q; Yu, B1
Liu, Y; Shen, Y; Tu, J; Ye, Z; Zhang, Y1
Aarnes, EK; Edin, NFJ; Fenne, S; Flatmark, K; Lyng, H; Mikalsen, LTG; Mikalsen, SG; Pettersen, EO; Sandvik, JA1
Arcaroli, JJ; Bagby, S; Bikkavilli, K; Cross, B; Eckhardt, SG; McPhillips, K; Messersmith, WA; Pitts, TM; Powell, RW; Purkey, A; Quackenbush, KS; Song, EK; Tai, WM; Tan, AC; Vanscoyk, M; Winn, RA1
Gharbi, O; Kassab, A; Lakhdar, R; Miled, A; Msolly, A1
Breder, VV; Gagarin, IM; Mazurenko, NN; Mochal'nikova, VV; Tsyganova, IV1
Al-Maghrabi, JA; Bakarman, M; Gar, MA; Gazzaz, ZJ; Ibrahim, AM; Khabaz, MN; Nedjadi, T1
Ciardiello, F; De Luca, A; Morgillo, F; Normanno, N; Tejpar, S; Van Cutsem, E1
Diaz, LA; Donehower, R; Holdhoff, M; Schmidt, K1
Bowman, R; Jeffery, H; Khaw, KT; Lentjes, MA; Loh, YH; Luben, RN; Mitrou, PN; Rodwell, SA; Wood, A1
Hu, YY; Jin, JQ; Leng, WD; Niu, YM; Wu, YY; Xia, LY; Yang, GL1
Diep, AT; Elkhouly, E; Frankl, H; Haile, RW; Lee, ER; Levine, AJ1
Cassagnau, E; Denis, MG; Jarry, A; Laboisse, C; Masson, D; Parois, S1
Bennett, D; Carpenter, KM; Durrant, LG; Hardcastle, JD; Kalsheker, NA; Morgan, K1
Al-Mulla, F; Birnie, GD; Going, JJ; Pickford, IR; Sowden, ET; Winter, A1
Al-Mulla, F; Andersen, SN; Andreyev, HJ; Arends, JW; Azuma, T; Bazan, V; Bell, S; Benamouzig, R; Benhattar, J; Beranek, M; Breivik, J; Bubb, VJ; Clarke, PA; Clausen, OP; Costa, J; Croke, CT; Cruickshank, NR; Cunningham, D; De Angelis, PD; de Goeij, AF; Dillon, D; Dix, BR; Faber, C; Finkelstein, SD; Font, A; Fox, JC; Fujimori, T; Gaudernack, G; Giaretti, W; Glaesener, R; Goh, HS; Hall, CN; Halter, SA; Hawkins, N; Ho, JW; Hoffmann, I; Iacopetta, BJ; Jandik, P; Jullian, E; Krtolica, K; Laurent-Puig, P; Lee, JQ; Lees, N; Losi, L; Lövig, T; Malik, S; Meling, GI; Morton, D; Muller, O; Norman, AR; O'Donoghue, DP; Oates, J; Ohkusa, T; Olschwang, S; Omura, K; Ono, Y; Pauly, M; Piris, J; Pricolo, VE; Quirke, P; Rabes, HM; Rapallo, A; Rognum, TO; Rosell, R; Russo, A; Senagore, AJ; Smith, R; Snary, D; Sun, XF; Tanaka, M; Thebo, JS; Troungos, C; Urosevic, N; Valavanis, C; Wadler, S; Walsh, T; Wang, ST; Ward, R; Wilkinson, K; Young, J; Yuen, ST; Zhang, H; Zietz, C1

Reviews

2 review(s) available for valine and Colorectal Neoplasms

ArticleYear
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.
    Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:9

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Aspartic Acid; Base Sequence; Biomarkers, Tumor; Cetuximab; Codon; Colorectal Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Exons; Genes, ras; Humans; Molecular Sequence Data; Neoplasm Metastasis; Panitumumab; Patient Selection; Point Mutation; ras Proteins; Signal Transduction; Valine

2009
CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
    World journal of gastroenterology, 2011, Jan-14, Volume: 17, Issue:2

    Topics: Case-Control Studies; Colorectal Neoplasms; Cytochrome P-450 CYP1A1; Female; Genotype; Humans; Isoleucine; Male; Models, Genetic; Odds Ratio; Polymorphism, Genetic; Risk; Risk Factors; Valine

2011

Other Studies

14 other study(ies) available for valine and Colorectal Neoplasms

ArticleYear
Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer.
    Cell death & disease, 2019, 08-13, Volume: 10, Issue:8

    Topics: Animals; Bevacizumab; Cell Proliferation; Cell Respiration; Cell Survival; Cholestenones; Citric Acid Cycle; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Molecular Targeted Therapy; Oxidative Phosphorylation; RNA, Messenger; Saponins; Survival Analysis; Thiolester Hydrolases; Valine; Xenograft Model Antitumor Assays

2019
EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Adsorption; Animals; Cattle; Cell Line, Tumor; Cell Survival; Cetuximab; Citrulline; Colorectal Neoplasms; Doxorubicin; Drug Delivery Systems; Endocytosis; ErbB Receptors; Humans; Immunoconjugates; Mice; Nanoparticles; Particle Size; Proton Magnetic Resonance Spectroscopy; Serum Albumin, Bovine; Tissue Distribution; Valine

2021
Low dose-rate irradiation with [
    Acta oncologica (Stockholm, Sweden), 2018, Volume: 57, Issue:9

    Topics: Animals; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Radiotherapy Dosage; Tritium; Tumor Hypoxia; Valine; Xenograft Model Antitumor Assays

2018
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model.
    British journal of cancer, 2013, Aug-06, Volume: 109, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Amyloid Precursor Protein Secretases; Animals; Cell Growth Processes; Colorectal Neoplasms; Enzyme Inhibitors; Female; Gene Knockdown Techniques; HCT116 Cells; Humans; Mice; Mice, Nude; Middle Aged; Random Allocation; Receptors, Notch; Tetrahydronaphthalenes; Valine; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2013
Polymorphisms of glutathione-S-transferases M1, T1, P1 and susceptibility to colorectal cancer in a sample of the Tunisian population.
    Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:1

    Topics: Adult; Aged; Alleles; Case-Control Studies; Colorectal Neoplasms; Female; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoleucine; Male; Middle Aged; Polymorphism, Genetic; Tunisia; Valine

2014
[The frequency and spectrum of KRAS mutations in metastatic colorectal cancer].
    Voprosy onkologii, 2013, Volume: 59, Issue:6

    Topics: Adult; Aged; Amino Acid Substitution; Aspartic Acid; Colorectal Neoplasms; Female; Glycine; Humans; Incidence; Male; Middle Aged; Mutation; Neoplasm Staging; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Valine

2013
Does Val/Val genotype of GSTP1 enzyme affects susceptibility to colorectal cancer in Saudi Arabia?.
    Neuro endocrinology letters, 2016, Volume: 37, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Colorectal Neoplasms; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Saudi Arabia; Valine

2016
Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
    Journal of the National Cancer Institute, 2009, Sep-16, Volume: 101, Issue:18

    Topics: Amino Acid Substitution; Colorectal Neoplasms; DNA, Neoplasm; Flow Cytometry; Glycine; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Sensitivity and Specificity; Valine

2009
MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
    DNA repair, 2010, Apr-04, Volume: 9, Issue:4

    Topics: Adult; Aged; Breast Neoplasms; Colorectal Neoplasms; Diet; DNA Modification Methylases; DNA Repair Enzymes; Female; Genotype; Humans; Isoleucine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Prostatic Neoplasms; Risk Factors; Tumor Suppressor Proteins; Valine

2010
The MnSOD A16V mitochondrial targeting sequence polymorphism is not associated with increased risk of distal colorectal adenomas: data from a sigmoidoscopy-based case control study.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:10 Pt 1

    Topics: Adenoma; Aged; Alanine; alpha-Tocopherol; Antioxidants; Case-Control Studies; Codon; Colorectal Neoplasms; Female; Genotype; Humans; Male; Middle Aged; Mitochondria; Point Mutation; Polymorphism, Genetic; Reactive Oxygen Species; Risk Factors; Sigmoidoscopy; Superoxide Dismutase; Valine

2002
Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.
    Molecular and cellular probes, 2004, Volume: 18, Issue:5

    Topics: Alleles; Cell Line, Tumor; Colorectal Neoplasms; Humans; Mutation; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Substrate Specificity; Valine

2004
Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methods.
    Clinical chemistry, 1996, Volume: 42, Issue:6 Pt 1

    Topics: Base Sequence; Colorectal Neoplasms; DNA Mutational Analysis; Genes, ras; Humans; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Valine

1996
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    The Journal of pathology, 1998, Volume: 185, Issue:2

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Genes, ras; Genetic Heterogeneity; Glycine; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Nucleic Acid Hybridization; Point Mutation; Polymerase Chain Reaction; Survival Rate; Valine

1998
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study.
    British journal of cancer, 2001, Sep-01, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Codon; Colorectal Neoplasms; Databases, Factual; Disease-Free Survival; Female; Genes, ras; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Mutation, Missense; Neoplasm Staging; Point Mutation; Proportional Hazards Models; Registries; Survival Analysis; Valine

2001